Literature DB >> 20228406

The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality.

Guenther Silbernagel1, Guenter Fauler, Michael M Hoffmann, Dieter Lütjohann, Bernhard R Winkelmann, Bernhard O Boehm, Winfried März.   

Abstract

Moderately elevated levels of plasma plant sterols have been suspected to be causally involved in atherosclerosis. The aim of this study was to investigate whether plant sterols and other markers of sterol metabolism predicted all-cause and cardiovascular mortality in participants of the Ludwigshafen Risk and Cardiovascular health (LURIC) study. A total of 1,257 individuals who did not use statins and at baseline had a mean (+/- SD) age of 62.8 (+/- 11.0) years were included in the present analysis. Lathosterol, cholestanol, campesterol, and sitosterol were measured to estimate cholesterol synthesis and absorption. The mean (+/- SD) time of the follow-up for all-cause and cardiovascular mortality was 7.32 (+/- 2.3) years. All-cause (P = 0.001) and cardiovascular (P = 0.006) mortality were decreased in the highest versus the lowest lathosterol to cholesterol tertile. In contrast, subjects in the third cholestanol to cholesterol tertile had increased all-cause (P < 0.001) and cardiovascular mortality (P = 0.010) compared with individuals in the first tertile. The third campesterol to cholesterol tertile was associated with increased all-cause mortality (P = 0.025). Sitosterol to cholesterol tertiles were not significantly related to all-cause or cardiovascular mortality. The data suggest that high absorption and low synthesis of cholesterol predict increased all-cause and cardiovascular mortality in LURIC participants.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228406      PMCID: PMC2903788          DOI: 10.1194/jlr.P002899

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  54 in total

1.  Serum plant sterols as a potential risk factor for coronary heart disease.

Authors:  Thomas Sudhop; Britta M Gottwald; Klaus von Bergmann
Journal:  Metabolism       Date:  2002-12       Impact factor: 8.694

2.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

3.  Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.

Authors:  Marc S Sabatine; David A Morrow; Kathleen A Jablonski; Madeline Murguia Rice; J Wayne Warnica; Michael J Domanski; Judith Hsia; Bernard J Gersh; Nader Rifai; Paul M Ridker; Marc A Pfeffer; Eugene Braunwald
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

Review 4.  Declaring war on undertreatment: rationale for an aggressive approach to lowering cholesterol.

Authors:  Marjel van Dam; Sanne van Wissen; John J P Kastelein
Journal:  J Cardiovasc Risk       Date:  2002-04

Review 5.  Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.

Authors:  B R Winkelmann; W März; B O Boehm; R Zotz; J Hager; P Hellstern; J Senges
Journal:  Pharmacogenomics       Date:  2001-02       Impact factor: 2.533

6.  Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action.

Authors:  M H Moghadasian; B M McManus; D V Godin; B Rodrigues; J J Frohlich
Journal:  Circulation       Date:  1999-04-06       Impact factor: 29.690

Review 7.  Phytosterols in human nutrition.

Authors:  Richard E Ostlund
Journal:  Annu Rev Nutr       Date:  2002-04-04       Impact factor: 11.848

8.  Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype.

Authors:  Klaus Von Bergmann; Dieter Lütjohann; Bernhard Lindenthal; Armin Steinmetz
Journal:  J Lipid Res       Date:  2003-01       Impact factor: 5.922

9.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

10.  Diabetes contributes to cholesterol metabolism regardless of obesity.

Authors:  Piia P Simonen; Helena K Gylling; Tatu A Miettinen
Journal:  Diabetes Care       Date:  2002-09       Impact factor: 19.112

View more
  17 in total

1.  Exploring the effect of vitamin D3 supplementation on surrogate biomarkers of cholesterol absorption and endogenous synthesis in patients with type 2 diabetes-randomized controlled trial.

Authors:  Huicui Meng; Nirupa R Matthan; Edith Angellotti; Anastassios G Pittas; Alice H Lichtenstein
Journal:  Am J Clin Nutr       Date:  2020-09-01       Impact factor: 7.045

Review 2.  Progress and perspectives in plant sterol and plant stanol research.

Authors:  Peter J H Jones; Maryam Shamloo; Dylan S MacKay; Todd C Rideout; Semone B Myrie; Jogchum Plat; Jean-Baptiste Roullet; David J Baer; Kara L Calkins; Harry R Davis; P Barton Duell; Henry Ginsberg; Helena Gylling; David Jenkins; Dieter Lütjohann; Mohammad Moghadasian; Robert A Moreau; David Mymin; Richard E Ostlund; Rouyanne T Ras; Javier Ochoa Reparaz; Elke A Trautwein; Stephen Turley; Tim Vanmierlo; Oliver Weingärtner
Journal:  Nutr Rev       Date:  2018-10-01       Impact factor: 7.110

3.  Low serum lathosterol levels associate with fatal cardiovascular disease and excess all-cause mortality: a prospective cohort study.

Authors:  Oliver Weingärtner; Dieter Lütjohann; Sven Meyer; Arne Fuhrmann; Bodo Cremers; Sarah Seiler-Mußler; Hans-F Schött; Anja Kerksiek; Silvia Friedrichs; Ursula Ulbricht; Adam Zawada; Ulrich Laufs; P Christian Schulze; Bruno Scheller; Danilo Fliser; Michael Böhm; Eric Sijbrands; Gunnar H Heine
Journal:  Clin Res Cardiol       Date:  2019-04-04       Impact factor: 5.460

4.  Plasma oxyphytosterol concentrations are not associated with CVD status in Framingham Offspring Study participants.

Authors:  Sabine Baumgartner; Rouyanne T Ras; Elke A Trautwein; Maurice C J M Konings; Ronald P Mensink; Jogchum Plat
Journal:  J Lipid Res       Date:  2019-08-27       Impact factor: 5.922

5.  The interrelations between PCSK9 metabolism and cholesterol synthesis and absorption.

Authors:  Günther Silbernagel; Lars K Steiner; Tim Hollstein; Günter Fauler; Hubert Scharnagl; Tatjana Stojakovic; Friederike Schumann; Bediha Bölükbasi; Winfried März; Elisabeth Steinhagen-Thiessen; Ulrich Laufs; Ursula Kassner
Journal:  J Lipid Res       Date:  2018-10-15       Impact factor: 5.922

Review 6.  [Congenital disorders of lipoprotein metabolism].

Authors:  W März; T B Grammer; G Delgado; M E Kleber
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

Review 7.  Plant sterol enriched functional food and atherosclerosis.

Authors:  Jürgen Köhler; Daniel Teupser; Albrecht Elsässer; Oliver Weingärtner
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

Review 8.  Plant sterols and cardiovascular disease: a systematic review and meta-analysis.

Authors:  Bernd Genser; Günther Silbernagel; Guy De Backer; Eric Bruckert; Rafael Carmena; M John Chapman; John Deanfield; Olivier S Descamps; Ernst R Rietzschel; Karen C Dias; Winfried März
Journal:  Eur Heart J       Date:  2012-02       Impact factor: 29.983

9.  Cholesterol synthesis is associated with hepatic lipid content and dependent on fructose/glucose intake in healthy humans.

Authors:  Guenther Silbernagel; Dieter Lütjohann; Juergen Machann; Sabrina Meichsner; Konstantinos Kantartzis; Fritz Schick; Hans-Ulrich Häring; Norbert Stefan; Andreas Fritsche
Journal:  Exp Diabetes Res       Date:  2011-11-29

10.  Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.

Authors:  Nirupa R Matthan; Lei Zhu; Michael Pencina; Ralph B D'Agostino; Ernst J Schaefer; Alice H Lichtenstein
Journal:  J Am Heart Assoc       Date:  2013-02-19       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.